K202215

Substantially Equivalent

cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit

Applicant: Roche Molecular Systems, Inc.
Product code: QMI
Advisory panel: Microbiology
Date received: 2020-08-06
Decision date: 2020-09-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Pleasanton, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.